| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1091504693 |
| P356 | DOI | 10.1186/S12879-017-2637-9 |
| P932 | PMC publication ID | 5588625 |
| P698 | PubMed publication ID | 28877682 |
| P50 | author | Emily Shing | Q88923361 |
| Beate Sander | Q39678012 | ||
| P2093 | author name string | Man Wah Yeung | |
| Mark Nelder | |||
| P2860 | cites work | The epidemiology and early clinical features of West Nile virus infection. | Q24169693 |
| Scoping studies: towards a methodological framework | Q24570441 | ||
| West Nile virus, Texas, USA, 2012 | Q24596533 | ||
| Long-term prognosis for clinical West Nile virus infection | Q24603453 | ||
| Risk factors for West Nile virus neuroinvasive disease, California, 2005 | Q24606540 | ||
| Clinical characteristics of the West Nile fever outbreak, Israel, 2000 | Q24644796 | ||
| West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral Ontario | Q27473563 | ||
| West Nile Encephalitis in Israel, 1999: The New York Connection | Q27487805 | ||
| Clinical Findings of West Nile Virus Infection in Hospitalized Patients, New York and New Jersey, 2000 | Q27487807 | ||
| West Nile Fever Outbreak, Israel, 2000: Epidemiologic Aspects | Q27487819 | ||
| Epidemiology of West Nile virus in the highly epidemic state of North Dakota, 2002-2007 | Q27490923 | ||
| West Nile virus meningoencephalitis | Q28260103 | ||
| The outbreak of West Nile virus infection in the New York City area in 1999 | Q29618175 | ||
| Initial and long-term costs of patients hospitalized with West Nile virus disease | Q30217299 | ||
| Endemic human mosquito-borne disease in Wisconsin residents, 2002-2006. | Q30229406 | ||
| A continental risk assessment of West Nile virus under climate change | Q30765842 | ||
| West Nile virus infection: a new acute paralytic illness | Q30809985 | ||
| West Nile virus neuroinvasive disease: neurological manifestations and prospective longitudinal outcomes | Q33610392 | ||
| Use of hospital discharge data to evaluate notifiable disease reporting to Colorado's Electronic Disease Reporting System | Q33825580 | ||
| Epidemiology of west nile in europe and in the mediterranean basin | Q33886961 | ||
| The West Nile Virus outbreak of 1999 in New York: the Flushing Hospital experience | Q33893693 | ||
| Survival analysis, long-term outcomes, and percentage of recovery up to 8 years post-infection among the Houston West Nile virus cohort | Q33940173 | ||
| Neurologic manifestations and outcome of West Nile virus infection | Q33967282 | ||
| Human surveillance for West Nile virus infection in Ontario in 2000. | Q34010838 | ||
| Clinical characteristics and functional outcomes of West Nile Fever | Q34346420 | ||
| CSF findings in 250 patients with serologically confirmed West Nile virus meningitis and encephalitis. | Q34480246 | ||
| Long-term clinical and neuropsychological outcomes of West Nile virus infection | Q34557857 | ||
| Clinical investigation of hospitalized human cases of West Nile virus infection in Houston, Texas, 2002-2004. | Q34590291 | ||
| Emergence of west nile virus lineage 2 in europe: a review on the introduction and spread of a mosquito-borne disease | Q34650104 | ||
| Focal neurological injury caused by West Nile virus infection may occur independent of patient age and premorbid health | Q35120864 | ||
| Prognosis of West Nile virus associated acute flaccid paralysis: a case series | Q35226007 | ||
| Long-term neurological outcomes in West Nile virus-infected patients: an observational study | Q35590664 | ||
| Follow-up of 2003 human West Nile virus infections, Denver, Colorado. | Q35792579 | ||
| West Nile Virus-associated flaccid paralysis outcome | Q35793924 | ||
| Lineage 1 and 2 strains of encephalitic West Nile virus, central Europe | Q35805636 | ||
| West Nile virus infection in the intensive care unit: a case series and literature review | Q35872745 | ||
| Economic cost analysis of West Nile virus outbreak, Sacramento County, California, USA, 2005. | Q35877366 | ||
| West Nile virus economic impact, Louisiana, 2002 | Q35880823 | ||
| Long-term Death Rates, West Nile virus epidemic, Israel, 2000. | Q36008731 | ||
| West Nile virus-associated flaccid paralysis | Q36021961 | ||
| Medical risk factors for severe West Nile Virus disease, United States, 2008-2010 | Q36080087 | ||
| Pediatric West Nile virus infection: neurologic disease presentations during the 2002 epidemic in Cuyahoga County, Ohio | Q36549604 | ||
| West Nile virus infection among humans, Texas, USA, 2002-2011. | Q36570918 | ||
| The long-term outcomes of human West Nile virus infection | Q36827974 | ||
| Lack of evidence of increased West Nile virus disease severity in the United States in 2012. | Q37456111 | ||
| A brief report of West Nile Virus neuroinvasive disease in the summer of 2012 in Hamilton, Ontario | Q37632418 | ||
| Functional outcomes of adult patients with West Nile virus admitted to a rehabilitation hospital | Q38025546 | ||
| Clinical features of West Nile virus epidemic in Dallas, Texas, 2012. | Q38169445 | ||
| Neuroinvasive arboviral disease in the United States: 2003 to 2012. | Q38239006 | ||
| Guidance for conducting systematic scoping reviews. | Q38541823 | ||
| Long-term sequelae of West Nile virus-related illness: a systematic review | Q38545145 | ||
| The 2012 West Nile encephalitis epidemic in Dallas, Texas | Q39383324 | ||
| Surveillance for human West Nile virus disease - United States, 1999-2008. | Q39886491 | ||
| Seasonality and survival associated with three outbreak seasons of West Nile virus disease in Oklahoma--2003, 2007, and 2012. | Q40157177 | ||
| Findings of long-term depression up to 8 years post infection from West Nile virus | Q40238557 | ||
| Neuroinvasive West Nile virus disease in Canada. The Saskatchewan experience | Q40243729 | ||
| Delayed mortality in a cohort of persons hospitalized with West Nile virus disease in Colorado in 2003. | Q40308164 | ||
| Surveillance of West Nile virus disease, Tel Aviv district, Israel, 2005 to 2010. | Q40319788 | ||
| Primary causes of death in reported cases of fatal West Nile Fever, United States, 2002-2006. | Q40351958 | ||
| Neurocognitive and functional outcomes in persons recovering from West Nile virus illness. | Q40377193 | ||
| West Nile virus disease in children, United States, 1999-2007. | Q40388299 | ||
| Associations between West Nile virus infection and symptoms reported by blood donors identified through nucleic acid test screening | Q40391646 | ||
| Risk factors for encephalitis from West Nile Virus: a matched case-control study using hospitalized controls | Q40398560 | ||
| West Nile viremic blood donors and risk factors for subsequent West Nile fever | Q40435427 | ||
| Human west nile virus neuroinvasive disease in Texas, 2003 epidemic: regional differences. | Q40469786 | ||
| Risk factors for encephalitis and death from West Nile virus infection. | Q40479908 | ||
| West Nile virus disease: a descriptive study of 228 patients hospitalized in a 4-county region of Colorado in 2003. | Q40482259 | ||
| West Nile virus infection in the pediatric population | Q40489437 | ||
| Surveillance for West Nile virus cases in Louisiana 2001-2004. | Q40490232 | ||
| Clinical description and follow-up investigation of human West Nile virus cases | Q40504273 | ||
| The emergence of west nile virus during a large outbreak in Illinois in 2002. | Q40505855 | ||
| Rehabilitation of West Nile Fever (WNF) encephalitis in elderly. | Q40507851 | ||
| Rehabilitation outcomes of 5 patients with severe West Nile virus infection: a case series | Q40513344 | ||
| Acute flaccid paralysis associated with West Nile virus: motor and functional improvement in 4 patients | Q40518888 | ||
| Cerebrospinal fluid neutrophilic pleocytosis in hospitalized West Nile virus patients. | Q40519851 | ||
| Neurological manifestations of West Nile virus infection. | Q40531877 | ||
| Assessment of surveillance of human West Nile virus infection in Quebec, 2003. | Q40532262 | ||
| The epidemic of West Nile virus in the United States, 2002. | Q40538334 | ||
| Severe West Nile virus disease in healthy adults | Q40543025 | ||
| Outcome of West Nile fever in older adults | Q40571643 | ||
| Neurological features of West Nile virus infection during the 2000 outbreak in a regional hospital in Israel | Q40578457 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | West Nile virus | Q158856 |
| West Nile fever | Q11627066 | ||
| RNA virus infectious disease | Q18967413 | ||
| scoping review | Q101116078 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 609 | |
| P577 | publication date | 2017-09-06 | |
| P1433 | published in | BMC Infectious Diseases | Q15759919 |
| P1476 | title | Epidemiologic and clinical parameters of West Nile virus infections in humans: a scoping review | |
| P478 | volume | 17 |
| Q61803642 | Acute and Delayed Deaths after West Nile Virus Infection, Texas, USA, 2002-2012 |
| Q42640648 | Health-related quality of life in persons with West Nile virus infection: a longitudinal cohort study |
| Q59350268 | Nonhuman primate models of human viral infections |
| Q92054805 | The direct healthcare costs attributable to West Nile virus illness in Ontario, Canada: a population-based cohort study using laboratory and health administrative data |
| Q89667356 | Understanding and managing acute encephalitis |
| Q91912294 | Zoonosis: Update on Existing and Emerging Vector-Borne Illnesses in the USA |
Search more.